PPD, Inc.
(NASDAQ : PPD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -4.44%216.907.5%$437.17m
EFXEquifax, Inc. -2.09%262.892.0%$163.19m
CPRTCopart, Inc. -2.38%140.534.4%$155.46m
CRLCharles River Laboratories International, Inc. -1.81%432.504.5%$152.15m
TWKSThoughtworks Holding, Inc. -6.07%32.320.0%$132.04m
TALTAL Education Group -5.74%4.360.7%$109.47m
FLTFLEETCOR Technologies, Inc. -1.41%254.593.6%$108.79m
CLVTClarivate Plc -3.77%23.260.0%$102.90m
MRVIMaravai Lifesciences Holdings, Inc. -0.39%45.890.0%$102.61m
BTBTBit Digital, Inc. -11.71%8.820.0%$94.68m
CHGGChegg, Inc. -5.60%73.8713.1%$92.91m
STMPStamps.com, Inc. 0.09%329.0023.6%$86.79m
FOURShift4 Payments, Inc. -1.33%80.400.0%$80.50m
BRBroadridge Financial Solutions, Inc. -1.62%163.871.5%$69.72m
PGNYProgyny, Inc. -5.15%58.390.0%$68.02m

Company Profile

PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.